CymaBay Therapeutics, Inc.

DEUTSCHE BANK AG\

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

1,377,964

Value ($000)

32,548

Weight

0.0%

2018 Q2 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	32,548	0.0%	1,377,964	12/31/2023
2023 Q3	11/24/2023	6,801	0.0%	456,106	9/30/2023
2023 Q2	8/14/2023	9,044	0.0%	825,957	6/30/2023
2023 Q1	5/15/2023	3,445	0.0%	395,089	3/31/2023
2022 Q4	2/13/2023	798	0.0%	127,196	12/31/2022
2022 Q3	11/14/2022	445	0.0%	127,196	9/30/2022
2022 Q2	8/11/2022	375	0.0%	127,196	6/30/2022
2022 Q1	5/13/2022	512	0.0%	164,703	3/31/2022
2021 Q4	2/16/2022	572	0.0%	169,280	12/31/2021
2021 Q3	11/4/2021	610	0.0%	167,066	9/30/2021
2021 Q2	8/11/2021	1,777	0.0%	407,559	6/30/2021
2021 Q1	5/13/2021	2,362	0.0%	520,240	3/31/2021
2020 Q4	2/16/2021	291	0.0%	50,650	12/31/2020
2020 Q3	11/12/2020	347	0.0%	47,881	9/30/2020
2020 Q2	8/13/2020	1,323	0.0%	379,157	6/30/2020
2020 Q1	5/14/2020	4,668	0.0%	3,154,427	3/31/2020
2019 Q4	2/14/2020	1,075	0.0%	549,419	12/31/2019
2018 Q3	12/21/2021	1,709	—	154,306	9/30/2018
2018 Q2	4/21/2020	1,825	—	135,960	6/30/2018